methylprednisolone has been researched along with Congestive Ophthalmopathy in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (19.26) | 29.6817 |
| 2010's | 83 (61.48) | 24.3611 |
| 2020's | 26 (19.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lanzolla, G; Leo, M; Marcocci, C; Marinò, M; Menconi, F; Nardi, M; Piaggi, P; Rocchi, R; Sabini, E; Sframeli, A | 1 |
| Campbell, AA | 1 |
| Barbesino, G; Batten, R; Cameron, C; Dailey, R; Douglas, RS; Qadeer, RA; Subramanian, PS; Ugradar, S | 1 |
| Baumann, A; Eibenberger, K; Neumayer, T; Papp, A; Rezar-Dreindl, S; Schmidt-Erfurth, U; Stifter, E | 1 |
| Comi, S; Figus, M; Lanzolla, G; Maglionico, MN; Marcocci, C; Marinò, M; Menconi, F; Piaggi, P; Posarelli, C | 1 |
| Miśkiewicz, P; Pelewicz, K; Przedlacki, J; Rymuza, J | 1 |
| Głogowska-Szeląg, J; Kajdaniuk, D; Kos-Kudła, B; Londzin-Olesik, M; Marek, B; Nowak, M; Nowak, W; Siemińska, L | 1 |
| Fukuchi, T; Hasegawa, Y; Hatase, T; Kiyokawa, M; Ueki, S | 1 |
| Kemchoknatee, P; Srisombut, T; Tangon, D | 1 |
| Miśkiewicz, P; Pelewicz-Sowa, M | 1 |
| Jang, JH; Kim, YD; Park, JW; Park, KA; Woo, KI | 1 |
| Choi, HY; Kim, J; Park, J; Ryu, D | 1 |
| Ebbehøj, E; Harsløf, T; Hikmet, R; Langdahl, B | 1 |
| Pakdel, F; Potvin, ARGG; Saeed, P | 1 |
| Bednarczuk, T; Miśkiewicz, P; Popow, M; Rymuza, J | 1 |
| Ko, JS; Kwak, J; Park, SJ; Shin, WB; Yoon, J | 1 |
| Cui, Y; Fu, D; Sun, F; Xu, N | 1 |
| Belfiore, A; Frasca, F; Le Moli, R; Lo Giudice, F; Malandrino, P; Russo, M; Vigneri, R | 1 |
| Ciric, J; Knezevic, M; Lalic, T; Miletic, M; Nedeljkovic Beleslin, B; Savic, S; Stankovic, B; Stojanovic, M; Stojkovic, M; Zarkovic, M | 1 |
| Airaldi, C; Bianco, L; Deandrea, M; Garino, F; Giannoccaro, F; Gino, E; Limone, PP; Mellano, M; Nassisi, D; Oldani, B; Rossi, A; Ruo Redda, MG | 1 |
| Campi, I; Covelli, D; Currò, N; Dazzi, D; Fugazzola, L; Guastella, C; Lazzaroni, E; Pignataro, L; Pirola, G; Salvi, M; Simonetta, S; Vannucchi, G | 1 |
| Karpe, J; Kos-Kudla, B; Londzin-Olesik, M; Nowak, A; Nowak, M | 1 |
| Campi, I; Covelli, D; Currò, N; Fugazzola, L; Guastella, C; Lazzaroni, E; Muller, I; Palomba, A; Salvi, M; Soranna, D; Vannucchi, G; Zambon, A | 1 |
| Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H | 1 |
| Karbownik-Lewinska, M; Lewinski, A; Stefanski, B; Stepniak, J; Wieczorek-Szukala, K; Wojciechowska-Durczynska, K; Zygmunt, A | 1 |
| Chen, L; Jiang, GH; Liu, P; Luo, B; Wang, QX; Yuan, G; Zhang, J | 1 |
| Bolanowski, M; Daroszewski, J; Grzegrzółka, J; Kolačkov, K; Mizera, Ł; Siomkajło, M; Szymczak, D | 1 |
| Górska, M; Hryniewicka, J; Jankowska, D; Kościuszko, M; Krętowski, A; Lipińska, D; Myśliwiec, J; Pawłowski, P; Popławska-Kita, A | 1 |
| Ambroziak, U; Bednarczuk, T; Bluszcz, G; Miśkiewicz, P | 1 |
| Abramavicius, S; Kadusevicius, E; Velickiene, D | 1 |
| Arao, T; Mori, H; Okada, Y; Tanaka, K; Tanaka, Y; Torimoto, K | 1 |
| Bodily, LM; Duncan, K; Sorrentino, D; Stefko, T; Taubenslag, KJ; Yu, JY | 1 |
| Ai, T; Hou, K; Hu, WK; Liu, R; Luo, B; Wu, YP | 1 |
| Lee, V; Lingam, RK; Mundada, P | 1 |
| Lam, L; Stack, R | 1 |
| Bartalena, L; Campi, I; Covelli, D; Curro, N; Diana, T; Eckstein, A; Führer, D; Kahaly, GJ; Kampmann, E; Kolbe, E; König, J; Leo, M; Marcocci, C; Marinò, M; Menconi, F; Moeller, LC; Perros, P; Pitz, S; Ponto, K; Riedl, M; Salvi, M; Wiersinga, WM | 1 |
| de-Pablo-Gómez-de-Liaño, L; Fernández-Vigo, JI; Gómez-de-Liaño, R; Niño-Rueda, C; Romo-López, Á; Troyano-Rivas, J | 1 |
| Bednarczuk, T; Kondracka, A; Milczarek-Banach, J; Miśkiewicz, P; Rutkowska-Hinc, B | 1 |
| Cibickova, L; Frysak, Z; Karasek, D; Karhanova, M; Kovarova, D; Schovanek, J | 1 |
| Castillo Laguarta, JM; Del Estad Cabello, A; España Gregori, E; Gessa Sorroche, M; Gomez-Reino, JJ; Maneiro, JR; Perez-Moreiras, JV; Perez-Pampin, E; Rodríguez Alvarez, FM; Romo Lopez, A; Sales-Sanz, M | 1 |
| David, J; Insull, EA; Keren, S; Norris, JH; Sipkova, Z; Turner, HE | 1 |
| Ding, X; He, M; Hu, S; Shi, B; Wang, Y; Zhang, M | 1 |
| Bednarczuk, T; Glowczynska, R; Milczarek-Banach, J; Miskiewicz, P; Opolski, G | 1 |
| Bednarczuk, T; Miśkiewicz, P; Popow, M; Przedlacki, J; Rymuza, J; Żurecka, Z | 1 |
| Cyranska-Chyrek, E; Olejarz, M; Pioch, A; Ruchala, M; Stajgis, P; Szczepanek-Parulska, E | 1 |
| Bartalena, L; Cusini, C; Masiello, E; Piantanida, E; Tanda, ML | 1 |
| Curragh, DS; Selva, D; Singh, S | 1 |
| Rose, GE; Verity, DH | 2 |
| Adamidou, F; Anagnostis, P; Karras, S; Poulasouchidou, M | 1 |
| Beck-Peccoz, P; Campi, I; Cirello, V; Covelli, D; Currò, N; Dazzi, D; Origo, D; Salvi, M; Vannucchi, G | 1 |
| Greenhill, C | 1 |
| Eckstein, LA; Hornbeak, DM; Tamhankar, MA | 1 |
| Beck-Peccoz, P; Campi, I; Covelli, D; Currò, N; Dazzi, D; Guastella, C; Pignataro, L; Pirola, G; Ratiglia, R; Salvi, M; Simonetta, S; Vannucchi, G | 1 |
| Litwin, AS; Malhotra, R | 1 |
| Han, R; Huang, F; Jiao, Q; Ning, G; Shen, L; Wang, S; Wang, W; Ye, L; Zhang, X; Zhu, W | 1 |
| Dai, J; Gao, G; Ma, F; Qian, Y | 1 |
| Esayag, Y; Goldin, E; Levi, I; Lurie, Y; Melamud, B | 1 |
| Hersh, D; Kinnar, M | 1 |
| Bin, L; Liu, J; Wang, J; Wang, Y; Ye, X | 1 |
| Al-Nawas, B; Kahaly, GJ; Karbach, J; Otto, AF; Pfeiffer, N; Pitz, S; Ponto, KA; Zwiener, I | 1 |
| Kajdaniuk, D; Karpe, J; Kos-Kudla, B; Marek, B; Nowak, M; Sieminska, L; Treszer, M | 1 |
| Fulcher, T; Kelly, R; McElnea, E; Moran, S; Ní Mhéalóid, A | 1 |
| Ambroziak, U; Bednarczuk, T; Główczyńska, R; Kahaly, G; Kryczka, A; Miśkiewicz, P; Opolski, G; Rutkowska, B | 1 |
| Higashiyama, T; Maegawa, H; Morino, K; Nishida, Y; Nishio, Y; Ohji, M; Ugi, S | 1 |
| Avignone, S; Beck-Peccoz, P; Campi, I; Covelli, D; Currò, N; Dazzi, D; Guastella, C; Pignataro, L; Salvi, M; Simonetta, S; Vannucchi, G | 1 |
| Kahaly, GJ; Kampmann, E; Kolbe, E; Krämer, I; Riedl, M | 1 |
| Huang, F; Ning, G; Shen, L; Wang, S; Wang, W; Ye, L; Zhang, X; Zhu, W | 1 |
| Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Mautone, T; Mazzi, B; Menconi, F; Nardi, M; Profilo, MA; Rocchi, R; Sisti, E; Vitti, P | 1 |
| Bargiota, A; Fountas, A; Giotaki, Z; Tigas, S; Tsatsoulis, A; Tsirouki, T | 1 |
| Albano, E; Brunetto, M; Coco, B; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Mazzi, B; Menconi, F; Profilo, MA; Rocchi, R; Sisti, E; Vitti, P | 1 |
| Beck-Peccoz, P; Campi, I; Covelli, D; Currò, N; D'Ambrosio, R; Gianelli, U; Maggioni, M; Salvi, M; Vannucchi, G | 1 |
| Mushtaq, F; Reuser, T; Yip, IY | 1 |
| Huang, F; Jiao, Q; Ning, G; Shen, L; Wang, S; Wang, W; Xing, L; Ye, L; Zhou, X; Zhu, W | 1 |
| Kajdaniuk, D; Karpe, J; Kos-Kudła, B; Marek, B; Nowak, M; Siemińska, L | 1 |
| Brunetto, M; Coco, B; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Mazzi, B; Menconi, F; Profilo, MA; Rocchi, R; Sisti, E; Vitti, P | 1 |
| Chen, J; Lin, J; Liu, R; Shen, T; Yan, J | 1 |
| Higashiyama, T; Nishida, Y; Ohji, M | 1 |
| Han, SH; Keum, KC; Kim, JW; Rim, TH; Son, BJ; Yoon, JS | 1 |
| Bednarczuk, T; Jabłońska, A; Kęcik, D; Krzeski, A; Milczarek-Banach, J; Miśkiewicz, P; Pirko-Kotela, K; Rutkowska, B; Samsel, A; Trautsolt-Jeziorska, K | 1 |
| Campennì, A; Giuffrida, G; Marinò, M; Moleti, M; Morelli, S; Puxeddu, E; Sisti, E; Squadrito, G; Sturniolo, G; Trimarchi, F; Vermiglio, F | 1 |
| Fushimi, Y; Inagaki, N; Kanamoto, N; Miura, M; Nakao, K; Okada, T; Sone, M; Tanaka-Mizuno, S; Togashi, K; Ueda-Sakane, Y; Yasoda, A; Yasuno, S | 1 |
| Wiersinga, WM | 1 |
| Czubilińska, J; Damasiewicz-Bodzek, A; Długaszek, M; Gawlik, K; Kos-Kudła, B; Krywult, A; Poczkaj, K; Strzelczyk, J; Synowiec, K; Szumska, M; Tyrpień-Golder, K | 1 |
| Dorner, G; Papp, A; Paridaens, D; Vasserot-Merle, C | 1 |
| He, Y; Liu, R; Mu, K; Xiang, N; Zhang, J | 1 |
| Bałdys-Waligórska, A; Jagiełło-Korzeniowska, A; Krzentowska-Korek, A; Miklaszewska, G; Sokołowski, A | 1 |
| Antunes, A; Ferreira, C; Marques, O; Meireles, C | 1 |
| Bar-Andziak, E; Grzesiuk, W; Pragacz, A; Szydlarska, D | 1 |
| Balazs, E; Berta, A; Bodor, M; Burman, KD; Cseke, B; Erdei, A; Galuska, L; Karanyi, Z; Leovey, A; Mezosi, E; Nagy, EV; Szabados, L; Ujhelyi, B; Varga, J | 1 |
| Alfayate Guerra, R; Arias Mendoza, N; González Sánchez, V; López Macia, A; Mauri Dot, M; Moreno-Pérez, O; Picó Alfonso, A; Sánchez-Ortiga, R | 1 |
| Feldt-Rasmussen, U; Fledelius, HC; Lendorf, ME; Rasmussen, AK | 1 |
| Galatoire, O; Jacomet, PV; Mehanna, C; Mensah, A; Morax, S; Morel, X; Vignal-Clermont, C | 1 |
| Bartalena, L | 1 |
| Führer, D; Papsdorf, K; Sterker, I; Tegetmeyer, H | 1 |
| Chang, TC; Hsiao, YL; Li, HY; Shih, SR | 1 |
| Iwata, M; Kabasawa, C; Kobayashi, M; Maruyama, K; Shimizu, Y; Uchiyama, S | 1 |
| Murakami, T; Nakashima, A; Noguchi, H; Noguchi, S; Noguchi, Y; Ohyabu, Y; Tachibana, S | 1 |
| Bhargava, J; Burns, J; Gregory, M; Sampath, R; Tambe, K; Tripathi, A | 1 |
| Blaha, M; Cap, J; Ceeova, V; Rezek, P; Skacha, M; Vlcek, P | 1 |
| Akarsu, E; Aktaran, S; Buyukhatipoglu, H; Kurtul, N | 1 |
| Schalin-Jäntti, C | 1 |
| Inoue, Y; Ito, K; Kosuga, Y; Kunii, Y; Matsumoto, M; Mukasa, K; Nakachi, A; Ohye, H; Sato, S; Sekiya, K; Suzuki, M; Watanabe, N; Yoshihara, A; Yoshimura Noh, J | 1 |
| Gasińska, T; Wichary, H | 1 |
| Altea, MA; Bartalena, L; Feldt-Rasmussen, U; Marcocci, C; Orgiazzi, J; Rasmussen, AK; Watt, T | 1 |
| Bahn, R | 1 |
| Beck-Peccoz, P; Bonara, P; Campi, I; Covelli, D; Currò, N; Dazzi, D; Guastella, C; Maffini, A; Pignataro, L; Ratiglia, R; Salvi, M; Vannucchi, G | 1 |
| Gorska, M; Kowalska, A; Mysliwiec, J; Nikolajuk, A; Palyga, I | 1 |
| Janićijević, K; Petrović, M; Petrović, MJ; Sarenac, T; Srećković, S; Vulović, D | 1 |
| Borowska, A; Dec, R; Gasińska, T; Wichary, H | 1 |
| Bunce, C; Lee, RW; Morley, AM; Rajendram, R | 1 |
| Kremlacek, J; Kuba, M; Kubova, Z; Langrova, J; Szanyi, J | 1 |
| Azzolini, C; Baldeschi, L; Bartalena, L; Bernard, M; Boboridis, KG; Boschi, A; Bournaud, C; Currò, N; Daumerie, C; Krassas, GE; Marcocci, C; Mourits, MP; Nardi, M; Salvi, M; Sassi, L; Soeters, MR; Stahl, M; Veronesi, G; von Arx, G; Wiersinga, W | 1 |
| Dickinson, AJ; Gan, EH; Johnson, K; Mitchell, AL; Morris, M; Neoh, C; Pearce, SH; Perros, P | 1 |
| Hsu, WM; Kao, SC; Kau, HC; Tsai, CC; Tsai, HH | 1 |
| Chan, MK; Choi, KL; Ng, CM; Ng, YW; Tiu, SC; Yuen, HK; Yuen, KT | 1 |
| Eguchi, N; Fukuhara, S; Furujo, M; Kanadani, T; Koyama, T; Kubo, T; Oshima, K; Shimizu, J; Shiraga, H; Takeuchi, A; Yoshioka-Iwaso, H | 1 |
| Amino, N; Fukata, S; Ito, M; Kubota, S; Kudo, T; Kuma, K; Miyauchi, A; Nishihara, E; Ohye, H | 1 |
| Avignone, S; Beck-Peccoz, P; Bonara, P; Campi, I; Guastella, C; Pirola, G; Ratiglia, R; Rossi, S; Salvi, M; Sbrozzi, F; Vannucchi, G | 1 |
| Aa, ZM; Li, SQ; Wei, SQ; Xie, Q; Zhao, HL | 1 |
| Owecki, M; Sowiński, J | 1 |
| Akarsu, E; Aktaran, S; Araz, M; Erbağci, I; Kartal, M; Okumuş, S | 1 |
| Wakelkamp, IM; Wiersinga, WM | 1 |
| Meyer, PA | 1 |
| Hiromatsu, Y | 1 |
| Campos-Pavón, J; Gutiérrez-Díaz, E; Mencía-Gutiérrez, E | 1 |
| Beck-Peccoz, P; Bonara, P; Campi, I; Currò, N; Dazzi, D; Guastella, C; Ratiglia, R; Rossi, S; Salvi, M; Simonetta, S; Sina, C; Vannucchi, G | 1 |
| Baldeschi, L; Lupetti, A; Prummel, MF; Vu, P; Wakelkamp, IM; Wiersinga, WM | 1 |
| Korczowska, I; Lacka, K; Lacki, JK; Manuszewska, E | 1 |
| Baldeschi, L; Le Moli, R; Mourits, MP; Regensburg, N; Saeed, P; Wiersinga, WM | 1 |
| Andrei, S; Enache, V; Renetti, A; Spiroiu, C; Zemba, M; Zugravu, V | 1 |
| Chang, TC; Hsiao, YL; Liao, SL | 1 |
| Buil, JA; Crespí, J; Rodríguez, F | 1 |
| Iwaki, M; Kakizaki, H; Zako, M | 1 |
| Beleslin, B; Ciric, J; Drezgic, M; Penezic, Z; Savic, S; Stojkovic, M; Trbojevic, B; Zarkovic, M | 1 |
12 review(s) available for methylprednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison.
Topics: Antibodies, Monoclonal, Humanized; Diplopia; Exophthalmos; Graves Ophthalmopathy; Humans; Methylprednisolone | 2022 |
Dysthyroid optic neuropathy: emerging treatment strategies.
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Methylprednisolone; Optic Nerve Diseases; Retrospective Studies | 2023 |
Dysthyroid Optic Neuropathy.
Topics: Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Optic Nerve; Papilledema | 2023 |
Acute thyroid eye disease (TED): principles of medical and surgical management.
Topics: Acute Disease; Decompression, Surgical; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Ophthalmologic Surgical Procedures | 2013 |
Severe eyelid oedema in Graves' ophthalmopathy.
Topics: Edema; Eyelid Diseases; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Middle Aged; Severity of Illness Index | 2013 |
Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
Topics: Administration, Oral; Combined Modality Therapy; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Methylprednisolone; Pulse Therapy, Drug; Radiotherapy | 2014 |
Is high dose intravenous methylprednisolone pulse therapy in patients with Graves' orbitopathy safe?
Topics: Administration, Intravenous; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Graves Ophthalmopathy; Humans; Methylprednisolone; Orbit; Severity of Illness Index; Treatment Outcome | 2014 |
Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.
Topics: Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged | 2016 |
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
Topics: Animals; Antibodies, Monoclonal; Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Immunologic Factors; Methylprednisolone; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Treatment Outcome | 2017 |
Orbital radiotherapy for adult thyroid eye disease.
Topics: Adult; Anti-Inflammatory Agents; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Steroids | 2012 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Ocular Motility Disorders; Prednisolone; Strabismus; Treatment Outcome; Visual Acuity; Visual Fields | 2006 |
[Steroid therapy for Graves' ophthalmopathy].
Topics: Administration, Oral; Combined Modality Therapy; Drug Administration Schedule; Graves Ophthalmopathy; Humans; Liver Failure; Liver Function Tests; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Randomized Controlled Trials as Topic; Triamcinolone | 2006 |
22 trial(s) available for methylprednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids.
Topics: Administration, Intravenous; Adult; Cytokines; Diagnostic Techniques, Ophthalmological; Dose-Response Relationship, Drug; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Inflammation Mediators; Male; Matched-Pair Analysis; Methylprednisolone; Middle Aged; Ocular Physiological Phenomena; Pilot Projects; Surface Properties; Tears; Treatment Outcome | 2020 |
Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
Topics: Administration, Intravenous; Adult; Antithyroid Agents; Diplopia; Exophthalmos; Eye Pain; Female; Glucocorticoids; Glycosides; Graves Disease; Graves Ophthalmopathy; Humans; Hypothyroidism; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Plant Extracts; Severity of Illness Index; Single-Blind Method; Thyroxine; Treatment Outcome; Tripterygium; Visual Acuity | 2021 |
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Double-Blind Method; Drug Therapy, Combination; Female; Graves Ophthalmopathy; Humans; Italy; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
Topics: Adult; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Resistance; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Receptors, Interleukin-6; Treatment Outcome | 2018 |
Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves' Orbitopathy.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulse Therapy, Drug; Severity of Illness Index | 2018 |
A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with graves' ophthalmopathy.
Topics: Administration, Intravenous; Adult; Aged; Cytokines; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Prednisone; Treatment Outcome | 2014 |
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Double-Blind Method; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Rituximab; Severity of Illness Index; Treatment Outcome | 2015 |
Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Topics: Combined Modality Therapy; Dose Fractionation, Radiation; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Ocular Motility Disorders; Oculomotor Muscles; Orbit; Pulse Therapy, Drug; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2016 |
Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
Topics: Administration, Intravenous; Adult; Female; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
[Driving competency after combined treatment with methylprednisolone and orbital radiotherapy for endocrine orbitopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Automobile Driver Examination; Automobile Driving; Chemoradiotherapy; Eligibility Determination; Germany; Graves Ophthalmopathy; Humans; Methylprednisolone; Middle Aged; Radiotherapy, Conformal; Treatment Outcome; Vision Disorders; Visual Acuity | 2010 |
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
Topics: Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Early Diagnosis; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Prednisolone; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2010 |
Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study.
Topics: Adult; Autoantibodies; Blood Component Removal; Evoked Potentials, Visual; Exophthalmos; Female; Graves Ophthalmopathy; Hemofiltration; Humans; Immunoglobulins; Methylprednisolone; Middle Aged; Treatment Outcome | 2010 |
Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.
Topics: Female; Graves Ophthalmopathy; Hepatitis B; Humans; Immunosuppressive Agents; Liver; Liver Function Tests; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug | 2012 |
Effect of methylprednisolone pulse therapy with and without alendronate on biochemical markers of bone turnover in patients with Graves' ophthalmopathy.
Topics: Absorptiometry, Photon; Adult; Alendronate; Anti-Inflammatory Agents; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Combined Modality Therapy; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug | 2012 |
A pilot study to monitor Graves' ophthalmopathy with a combination of pattern-reversal and motion-onset visual evoked potentials.
Topics: Administration, Oral; Adult; Blood Component Removal; Combined Modality Therapy; Decompression, Surgical; Drug Monitoring; Evoked Potentials, Visual; Female; Graves Ophthalmopathy; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Methylprednisolone; Middle Aged; Pilot Projects; Prednisone; Pulse Therapy, Drug; Reaction Time; Treatment Outcome; Visual Acuity | 2012 |
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
Topics: Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Orbit; Severity of Illness Index; Treatment Outcome | 2012 |
Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Eye; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisolone; Prospective Studies; Pulsatile Flow; Regional Blood Flow; Severity of Illness Index; Treatment Outcome | 2006 |
Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Topics: Administration, Oral; Analysis of Variance; Chi-Square Distribution; Combined Modality Therapy; Double-Blind Method; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisolone; Prospective Studies; Statistics, Nonparametric; Treatment Outcome | 2005 |
Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves' disease.
Topics: Administration, Oral; Adult; Autoantibodies; Case-Control Studies; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulin E; Immunoglobulins, Thyroid-Stimulating; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Receptors, Thyrotropin; Remission Induction; Time Factors; Treatment Outcome | 2005 |
Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
Topics: Administration, Oral; Adult; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Prospective Studies; Quality of Life; Treatment Outcome | 2007 |
Avoiding surgery for thyroid eye disease.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Ocular Motility Disorders; Prednisolone; Strabismus; Treatment Outcome; Visual Acuity; Visual Fields | 2006 |
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Rituximab; Thyroid Function Tests; Thyroid Hormones | 2007 |
102 other study(ies) available for methylprednisolone and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.
Topics: Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Treatment Outcome | 2021 |
Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease: Is There Still a Role for Steroids?
Topics: Antibodies, Monoclonal, Humanized; Graves Ophthalmopathy; Humans; Methylprednisolone; Steroids | 2022 |
Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.
Topics: Adrenal Cortex Hormones; Adult; Decompression, Surgical; Exophthalmos; Graves Ophthalmopathy; Humans; Methylprednisolone; Optic Nerve Diseases; Orbit; Retrospective Studies | 2022 |
Sirolimus as a second-line treatment for Graves' orbitopathy.
Topics: Exophthalmos; Graves Ophthalmopathy; Humans; Methylprednisolone; Quality of Life; Sirolimus; Treatment Outcome | 2022 |
Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves' Orbitopathy: A Pilot Study.
Topics: Cancellous Bone; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Pilot Projects | 2022 |
[Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z
Topics: Glucocorticoids; Graves Disease; Graves Ophthalmopathy; Humans; Methylprednisolone; Rituximab | 2022 |
One-year recurrence rate of Graves ophthalmopathy presenting as diplopia in the primary position after varied doses of intravenous methylprednisolone followed by oral prednisolone with dosing based on the magnetic resonance imaging findings.
Topics: Aged; Diplopia; Female; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Retrospective Studies | 2023 |
A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
Topics: Exophthalmos; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Middle Aged; Optic Nerve Diseases | 2023 |
Early response to intravenous methylprednisolone therapy for restrictive myopathy in patients with thyroid eye disease.
Topics: Graves Ophthalmopathy; Humans; Methylprednisolone; Muscular Diseases; Oculomotor Muscles; Prospective Studies; Retrospective Studies; Treatment Outcome | 2023 |
Factors related to steroid treatment responsiveness in thyroid eye disease patients and application of SHAP for feature analysis with XGBoost.
Topics: Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Methylprednisolone; Oculomotor Muscles; Retrospective Studies | 2023 |
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves' orbitopathy.
Topics: Bone Density; Bone Remodeling; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone | 2023 |
High dose intravenous methylprednisolone pulse therapy causes transient increase of serum calcium and phosphate levels.
Topics: Calcium; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Phosphates | 2019 |
Anti-
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Drug Combinations; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Methylprednisolone; Receptors, N-Methyl-D-Aspartate; Tomography, X-Ray Computed | 2019 |
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism.
Topics: Adrenal Cortex Hormones; Adult; Antithyroid Agents; Female; Graves Disease; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2020 |
Comparison of efficacy and safety of parenteral versus parenteral and oral glucocorticoid therapy in Graves' orbitopathy.
Topics: Administration, Intravenous; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Retrospective Studies | 2020 |
Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
Topics: Combined Modality Therapy; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Severity of Illness Index; Steroids | 2021 |
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Diplopia; Eye Movement Measurements; Eye Movements; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Predictive Value of Tests; Quality of Life; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2021 |
The Effect of Immunosuppression on Selected Antioxidant Parameters in Patients with Graves' Disease with Active Thyroid-Associated Orbitopathy.
Topics: Adult; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Lipid Peroxidation; Male; Methylprednisolone; Middle Aged; Oxidative Stress | 2021 |
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.
Topics: Adult; Cytokine Release Syndrome; Decompression, Surgical; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Quality of Life; Rituximab; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2021 |
Percentage of Myeloid Dendritic Cells in Peripheral Venous Blood Is Negatively Related to Incidence of Graves' Orbitopathy.
Topics: Adult; Aged; Autoimmunity; Dendritic Cells; Female; Flow Cytometry; Graves Ophthalmopathy; Humans; Incidence; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Myeloid Cells; Orbit; Regression Analysis; Steroids | 2021 |
Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
Topics: Adult; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Prognosis; Retrospective Studies; Treatment Outcome | 2021 |
Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.
Topics: Diplopia; Drug Monitoring; Female; Flow Cytometry; Glucocorticoids; Graves Ophthalmopathy; Humans; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Patient Acuity; Pulse Therapy, Drug; Severity of Illness Index; T-Lymphocytes, Regulatory; Th17 Cells; Treatment Outcome; Visual Acuity | 2021 |
Clinical relevance of estimating circulating interleukin-17 and interleukin-23 during methylprednisolone therapy in Graves' orbitopathy: A preliminary study.
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Interleukin-17; Interleukin-23; Methylprednisolone | 2021 |
The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function.
Topics: Administration, Intravenous; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aged; Drug Therapy, Combination; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydrocortisone; Male; Methylprednisolone; Middle Aged; Pituitary-Adrenal System; Prednisone; Young Adult | 2017 |
Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report.
Topics: Administration, Intravenous; Aged; Antithyroid Agents; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Liver Function Tests; Medication Therapy Management; Methimazole; Methylprednisolone; Optic Nerve Diseases; Pulse Therapy, Drug; Symptom Assessment; Thyrotoxicosis; Treatment Outcome | 2017 |
The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy.
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Graves Ophthalmopathy; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Male; Methylprednisolone; Middle Aged; Piperidines; Treatment Outcome | 2018 |
Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
Topics: Cavernous Sinus; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Magnetic Resonance Angiography; Methylprednisolone; Middle Aged; Orbital Diseases; Tomography, X-Ray Computed; Venous Thrombosis | 2018 |
Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Eye Movements; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Intraocular Pressure; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Prospective Studies; Severity of Illness Index; Treatment Outcome; Visual Acuity | 2017 |
Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study.
Topics: Adult; Aged; Cohort Studies; Diffusion Magnetic Resonance Imaging; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Monitoring, Physiologic; Observer Variation; Oculomotor Muscles; Orbit; Retrospective Studies; Young Adult | 2018 |
The blinding thyroid gland.
Topics: Aged; Blindness; Decompression, Surgical; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Tomography, X-Ray Computed; Visual Acuity | 2018 |
Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
Topics: Adult; Aged; Anthropometry; Antibodies, Monoclonal, Humanized; Case-Control Studies; Conjunctival Diseases; Drug Therapy, Combination; Edema; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Observer Variation; Oculomotor Muscles; Prospective Studies; Reproducibility of Results; Tomography, Optical Coherence | 2018 |
High-dose intravenous methylprednisolone therapy in patients with Graves' orbitopathy is associated with the increased activity of factor VIII.
Topics: Adult; Aged; Anti-Inflammatory Agents; Factor VIII; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Young Adult | 2019 |
RETROSPECTIVE ANALYSIS OF PATIENTS WITH GRAVES ORBITOPATHY TREATED BY PULSES OF METHYLPREDNISOLONE, WITH A FOCUS ON ADVERSE EVENTS.
Topics: Administration, Intravenous; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Retrospective Studies | 2018 |
Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Aged; Aged, 80 and over; Female; Graves Ophthalmopathy; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Retrospective Studies | 2018 |
Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: A single-centre retrospective study.
Topics: Administration, Intravenous; Adult; Female; Graves Ophthalmopathy; Humans; Logistic Models; Male; Methylprednisolone; Middle Aged; Prognosis; Retrospective Studies; Thyrotropin; Triglycerides | 2019 |
Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Femur Neck; Glucocorticoids; Graves Ophthalmopathy; Humans; Lumbar Vertebrae; Methylprednisolone; Middle Aged; Osteoporosis; Young Adult | 2019 |
Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report.
Topics: Adolescent; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Hashimoto Disease; Humans; Methylprednisolone; Treatment Outcome | 2019 |
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?
Topics: Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Severity of Illness Index | 2019 |
Augmented endoscopic orbital apex decompression in dysthyroid optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Decompression, Surgical; Endoscopy; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Orbit; Retrospective Studies; Visual Acuity; Visual Fields | 2019 |
The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
Topics: Adult; Aged; Cohort Studies; Diplopia; Drug Resistance; Exophthalmos; Female; Genetic Association Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Infusions, Intravenous; Italy; Male; Methylprednisolone; Middle Aged; Polymorphism, Genetic; Receptors, Glucocorticoid; Severity of Illness Index; Time Factors | 2014 |
Thyroid gland: Duration of intravenous glucocorticoid therapy in patients with Graves ophthalmopathy.
Topics: Drug Resistance; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Polymorphism, Genetic; Receptors, Glucocorticoid | 2014 |
No light perception vision from compressive thyroid orbitopathy.
Topics: Aged; Blindness; Combined Modality Therapy; Decompression, Surgical; Exophthalmos; Glucocorticoids; Graves Ophthalmopathy; Humans; Hypertrophy; Infusions, Intravenous; Magnetic Resonance Angiography; Male; Methylprednisolone; Nerve Compression Syndromes; Oculomotor Muscles; Optic Nerve Diseases; Visual Acuity | 2014 |
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Combined Modality Therapy; Decompression, Surgical; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Optic Nerve; Papilledema; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Vision, Ocular | 2014 |
Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'.
Topics: Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Ophthalmologic Surgical Procedures | 2014 |
Response to Drs Litwin and Malhotra.
Topics: Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone; Ophthalmologic Surgical Procedures | 2014 |
Methylprednisolone-induced liver injury: a diagnostic challenge.
Topics: Administration, Intravenous; Chemical and Drug Induced Liver Injury; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug | 2014 |
Acute dysthyroid optic neuropathy exacerbated by orbital radiotherapy.
Topics: Acute Disease; Aged; Decompression, Surgical; Disease Progression; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Optic Nerve Diseases; Orbit; Radiotherapy; Visual Acuity | 2014 |
Increased serum VEGF and b-FGF in Graves' ophthalmopathy.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor 2; Glucocorticoids; Graves Ophthalmopathy; Healthy Volunteers; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Piezosurgery for orbital decompression surgery in thyroid associated orbitopathy.
Topics: Adult; Aged; Decompression, Surgical; Endoscopy; Exophthalmos; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Hypesthesia; Intraoperative Complications; Longitudinal Studies; Male; Methylprednisolone; Middle Aged; Nerve Compression Syndromes; Optic Nerve Diseases; Orbit; Piezosurgery; Postoperative Complications; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Serum concentration of VEGF and PDGF-AA in patients with active thyroid orbitopathy before and after immunosuppressive therapy.
Topics: Adult; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Platelet-Derived Growth Factor; Treatment Outcome; Vascular Endothelial Growth Factor A | 2014 |
Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab.
Topics: Aged; Antibodies, Monoclonal; Euthyroid Sick Syndromes; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Ipilimumab; Melanoma; Methylprednisolone; Ophthalmoplegia; Thyroid Function Tests; Thyrotropin; Thyroxine | 2014 |
Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Diplopia; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Prednisolone; Pulse Therapy, Drug; Young Adult | 2015 |
Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.
Topics: Administration, Intravenous; Adult; Adverse Drug Reaction Reporting Systems; Aged; Female; Gastrointestinal Diseases; Graves Ophthalmopathy; Heart Diseases; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Severity of Illness Index; Young Adult | 2015 |
Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves' ophthalmopathy.
Topics: Adult; Biomarkers; Dexamethasone; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Methylprednisolone; MicroRNAs; Middle Aged | 2015 |
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
Topics: Adult; Aged; Combined Modality Therapy; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Thyroid Gland; Treatment Outcome; Visual Acuity | 2015 |
Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids.
Topics: Administration, Intravenous; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenal Insufficiency; Aged; Biomarkers; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydrocortisone; Male; Methylprednisolone; Middle Aged; Predictive Value of Tests; Pulse Therapy, Drug; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
Topics: Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Middle Aged; Simvastatin | 2015 |
A difficult diagnosis: severe Graves' ophthalmolopathy.
Topics: Accidental Falls; Aged, 80 and over; Atrial Fibrillation; Drug Therapy, Combination; Exophthalmos; Eye Movements; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hyperthyroidism; Methylprednisolone | 2015 |
Smoking was associated with poor response to intravenous steroids therapy in Graves' ophthalmopathy.
Topics: Adult; Aged; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Smoke Pollution; Young Adult | 2015 |
Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Graves Ophthalmopathy; Hepatocyte Growth Factor; Humans; Interleukin-8; Male; Methylprednisolone; Middle Aged | 2016 |
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Cohort Studies; Dose-Response Relationship, Drug; Female; gamma-Glutamyltransferase; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Multivariate Analysis; Regression Analysis; Retrospective Studies; Risk Factors; Young Adult | 2015 |
Concomitant Idiopathic Orbital Inflammatory Pseudotumor and Thyroid-Associated Ophthalmopathy.
Topics: Adult; Anti-Inflammatory Agents; Blepharoptosis; Dexamethasone; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Ocular Motility Disorders; Orbit; Orbital Pseudotumor; Prednisone; Tendons; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2015 |
Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
Topics: Adipose Tissue; Aged; Exophthalmos; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Orbital Diseases; Pulse Therapy, Drug; Retrospective Studies | 2015 |
Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
Topics: Adult; Aged; Color Vision Defects; Combined Modality Therapy; Decompression, Surgical; Female; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Retrospective Studies; Treatment Outcome; Visual Acuity | 2016 |
Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Determination of advanced glycation end-products and antibodies against them (anti-CML and anti-CEL) in the serum of Graves' orbitopathy patients before and after methylprednisolone treatment.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Female; Glycation End Products, Advanced; Graves Ophthalmopathy; Humans; Lysine; Male; Methylprednisolone; Middle Aged | 2016 |
Severe pediatric Graves orbitopathy in adolescents of African origin.
Topics: Adolescent; Africa, Western; Black People; Exophthalmos; Glucocorticoids; Graves Ophthalmopathy; Humans; Intraocular Pressure; Male; Methylprednisolone; Nigeria; Orbital Diseases; Pulse Therapy, Drug; Tomography, X-Ray Computed | 2016 |
The efficacy of immunosuppressive treatment of Graves' orbitopathy is not affected by previous anti-thyroid drugs or by radioiodine therapy of Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Iodine Radioisotopes; Male; Methylprednisolone; Middle Aged; Treatment Outcome | 2016 |
Therapeutic challenge of a paediatric case of Graves' disease with severe ophthalmopathy.
Topics: Antithyroid Agents; Child, Preschool; Female; Glucocorticoids; Goiter; Graves Ophthalmopathy; Humans; Methylprednisolone; Propranolol; Remission Induction; Thyroid Function Tests; Thyroidectomy | 2017 |
Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report.
Topics: Adult; Anemia, Pernicious; Autoantibodies; Graves Ophthalmopathy; Hashimoto Disease; Humans; Male; Methylprednisolone; Thyrotropin; Thyroxine | 2008 |
Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
Topics: Adult; Aged; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Orbit; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Treatment Outcome | 2009 |
Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone: a comparison of two dosing regimens.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Female; Graves Ophthalmopathy; Hashimoto Disease; Humans; Hyperglycemia; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Treatment Outcome | 2009 |
Cardiovascular and cerebrovascular events in temporal relationship to intravenous glucocorticoid pulse therapy in patients with severe endocrine ophthalmopathy.
Topics: Aged; Cardiovascular Diseases; Cerebral Infarction; Coronary Thrombosis; Fatal Outcome; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Methylprednisolone; Myocardial Infarction; Pulmonary Embolism; Young Adult | 2009 |
Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
Topics: Age of Onset; Decompression, Surgical; Evoked Potentials, Visual; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Prognosis; Retrospective Studies; Risk Factors; Vision Disorders; Visual Acuity | 2009 |
What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
Topics: Administration, Oral; Algorithms; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections, Intravenous; Methylprednisolone; Practice Guidelines as Topic; Salvage Therapy; Severity of Illness Index; Treatment Failure | 2010 |
The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
Topics: Adult; Aged; Body Temperature; Eye; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Inflammation; Infrared Rays; Male; Methylprednisolone; Middle Aged; Prognosis; Pulse Therapy, Drug; ROC Curve; Thermography; Treatment Outcome; Young Adult | 2010 |
[Thyroid-associated ophthalmopathy: case report of a euthyroid patient].
Topics: Diagnosis, Differential; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Pulse Therapy, Drug | 2010 |
The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease.
Topics: Exophthalmos; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppression Therapy; Infusions, Intravenous; Methylprednisolone; Oculomotor Muscles; Retrospective Studies; Treatment Outcome | 2010 |
Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Topics: Adult; Anti-Inflammatory Agents; Female; Glutathione; Graves Ophthalmopathy; Humans; Iodide Peroxidase; Male; Malondialdehyde; Methylprednisolone; Oxidative Stress; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2011 |
[Management of Graves' ophthalmopathy].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Graves Ophthalmopathy; Humans; Immunologic Factors; Infusions, Intravenous; Methylprednisolone; Optic Nerve Diseases; Orthopedics; Rituximab | 2010 |
Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases.
Topics: Adult; Female; Graves Ophthalmopathy; Hashimoto Disease; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Orbit; Prednisone; Thyroxine | 2011 |
Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Committee Membership; Data Collection; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Endocrinology; Europe; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Practice Patterns, Physicians'; Societies, Medical; Surveys and Questionnaires; Thyroid Gland; Young Adult | 2012 |
High-dose intravenous glucocorticoid therapy for Graves' ophthalmopathy: where are we now?
Topics: Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Liver; Male; Methylprednisolone | 2012 |
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; B-Cell Activating Factor; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Rituximab; Treatment Outcome | 2012 |
Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chemokine CCL5; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Injections, Intravenous; Interleukin-16; Male; Methylprednisolone; Middle Aged; Radioimmunoassay; Radioisotope Teletherapy; Receptors, Thyrotropin; Severity of Illness Index; Young Adult | 2012 |
Evaluation of the patients with Grave's ophthalmopathy after the corticosteroids treatment.
Topics: Adult; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Pulse Therapy, Drug | 2012 |
The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Male; Methylprednisolone; Middle Aged; Receptors, Thyrotropin; Rituximab; Thyrotropin; Treatment Outcome | 2013 |
An infant case of Graves' disease with ophthalmopathy.
Topics: Child, Preschool; Entropion; Female; Graves Ophthalmopathy; Humans; Methylprednisolone; Tears | 2005 |
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Female; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; Immunohistochemistry; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Methylprednisolone; Middle Aged; Orbit; Receptors, Thyrotropin; Rituximab; T-Lymphocytes; Thyroidectomy; Thyrotropin; Thyroxine | 2006 |
[Serum IL-1 receptor antagonist and IL-1beta in patients with Graves' opthalmopathy].
Topics: Adult; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Interleukin-1beta; Male; Methylprednisolone; Middle Aged; Receptors, Interleukin-1 | 2006 |
Acute myocardial infarction during high-dose methylprednisolone therapy for Graves' ophthalmopathy.
Topics: Aged; Blood Pressure; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hypertension; Methylprednisolone; Myocardial Infarction | 2006 |
Author's response: medical or surgical decompression of optic neuropathy in Graves' ophthalmopathy: the choice remains unclear.
Topics: Decompression, Surgical; Glucocorticoids; Graves Ophthalmopathy; Humans; Methylprednisolone | 2006 |
[Malignant exophtalmos in hyperthyroidism with a hypothyroid crisis].
Topics: Acute Disease; Adipose Tissue; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibitors; Combined Modality Therapy; Decompression, Surgical; Drug Therapy, Combination; Exophthalmos; Eye Enucleation; Glaucoma; Graves Ophthalmopathy; Humans; Hypothyroidism; Male; Methylprednisolone; Middle Aged; Orbit | 2006 |
Reactivation of Graves' orbitopathy after rehabilitative orbital decompression.
Topics: Aged; Decompression, Surgical; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppression Therapy; Incidence; Methylprednisolone; Middle Aged; Orbit; Prednisone; Radiotherapy; Recurrence; Reoperation; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Interleukin-13; Interleukin-4; Interleukin-6; Methylprednisolone; Middle Aged; Pulse Therapy, Drug | 2007 |
Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Follow-Up Studies; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Liver Failure; Male; Methylprednisolone; Middle Aged; Prospective Studies | 2007 |
[Treatment of thyroid ophthalmopathy--a clinical case].
Topics: Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Nicergoline; Optic Nerve Diseases; Risk Factors; Smoking; Treatment Outcome; Vasodilator Agents; Visual Field Tests; Vitamin B Complex | 2007 |
Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.
Topics: Adult; Aged; Body Temperature; Conjunctiva; Cornea; Eyelids; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Image Interpretation, Computer-Assisted; Inflammation; Infrared Rays; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Orbit; Pulse Therapy, Drug; Thermography | 2008 |
[Intraocular pressure after treatment for thyroid-associated ophthalmopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Data Interpretation, Statistical; Decompression, Surgical; Diplopia; Exophthalmos; Female; Glaucoma; Graves Ophthalmopathy; Humans; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Oculomotor Muscles; Optic Neuritis; Orbit; Postoperative Period; Pulse Therapy, Drug; Retrospective Studies; Strabismus | 2007 |
Thyroid-associated inferior oblique myopathy.
Topics: Adult; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Methylprednisolone; Oculomotor Muscles; Ophthalmoplegia; Pulse Therapy, Drug | 2007 |
Glucocorticoid effect on insulin sensitivity: a time frame.
Topics: Adult; Glucocorticoids; Glucose Clamp Technique; Graves Ophthalmopathy; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Methylprednisolone; Middle Aged; Prednisone; Time Factors | 2008 |